Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
31.93
-1.07 (-3.24%)
Nov 13, 2026, 10:16 AM EST - Market open
Definium Therapeutics Market Cap
Definium Therapeutics has a market cap or net worth of $4.37 billion as of November 13, 2026. It is the 3,868th most valuable company in the world and the 1,229th biggest in the United States. Its market cap has increased by 265.52% in one year.
Market Cap
4.37B
Enterprise Value
3.36B
1-Year Change
265.52%
Global Rank
Country Rank
#1,229 United States
Category
ChartMarket Cap Chart
Since March 4, 2020, Definium Therapeutics's market cap has increased from $595.37M to $4.37B, an increase of 634.21%. That is a compound annual growth rate of 34.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 4.37B | 231.39% |
| Dec 31, 2025 | 1.32B | 158.44% |
| Dec 31, 2024 | 510.39M | 247.80% |
| Dec 29, 2023 | 146.75M | 77.54% |
| Dec 30, 2022 | 82.66M | -85.99% |
| Dec 31, 2021 | 590.17M | -82.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PTC Therapeutics | 5.42B |
| Edgewise Therapeutics | 5.21B |
| Cogent Biosciences | 5.12B |
| Dianthus Therapeutics | 5.03B |
| Travere Therapeutics | 5.00B |
| Ionis Pharmaceuticals | 4.72B |
| CRISPR Therapeutics AG | 4.44B |
| Tango Therapeutics | 4.36B |